Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STX-S
- Development stage
- Phase 1
- Lead developer
- Capricor Therapeutics
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
STX-S is an investigational exosome-based COVID-19 vaccine being developed by Capricor Therapeutics in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The vaccine platform utilizes proprietary exosomes engineered to express the SARS-CoV-2 spike (S) protein on their surface. By presenting the viral antigen in this manner, STX-S aims to stimulate a robust immune response. It is currently being evaluated in a Phase 1 dose-escalation study as a booster dose in healthy adults who have previously received primary COVID-19 vaccinations. This development program is supported by the U.S. government's Project NextGen initiative, which focuses on advancing next-generation vaccine technologies.
- Other names
- StealthX-spikeStealthX spikeexosome-mRNA vaccine (SARS-CoV-2)exosome COVID-19 mRNA vaccineexosome-based SARS-CoV-2 vaccine
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on STX-S.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STX-S.